From: Assessing neutrophil-derived ROS production at the bedside: a potential prognostic tool in severe COVID-19 cases
Group
N
Mean ± SD
Median (IQR)
Healthy
19
0.059 ± 0.026
0.054 (0.043–0.066)
COVID
44
0.174 ± 0.065
0.172 (0.121–0.218)